Homebiotech

biotech

Aquestive Therapeutics Provides Business Update

Aquestive Therapeutics Provides Business Update

January 7, 2021

APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia

APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia

January 7, 2021

Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences

Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences

January 7, 2021

aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

January 7, 2021

Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones

Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones

January 7, 2021

Affimed Announces Pipeline and Business Update

Affimed Announces Pipeline and Business Update

January 7, 2021

Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference

Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference

January 7, 2021

Celyad Oncology Announces Equity Purchase Agreement for up to $40 Million with Lincoln Park Capital

Celyad Oncology Announces Equity Purchase Agreement for up to $40 Million with Lincoln Park Capital

January 7, 2021

IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. – FBIO

IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. – FBIO

January 6, 2021

Aptevo Therapeutics Inc. (APVO) Upgraded to Buy: Here’s Why

Aptevo Therapeutics Inc. (APVO) Upgraded to Buy: Here’s Why

January 6, 2021

« 1 … 529 530 531 532 533 … 558 »